Smoking cessation counseling in patients with active malignancy.

• DOI: 10.1200/jco.2022.40.16_suppl.e18655
• Publication Date: 2022-06-06T16:40:01Z
• Authors: Zachary M Avigan; Leora S Boussi; Kenneth J. Mukamal
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

e18655 Background: Tobacco smoking increases risk of multiple malignancies, most notably lung cancer, and is a leading cause premature morbidity mortality. cessation counseling effective in assisting patients to quit improving health outcomes, but over one third smokers report receiving no by healthcare providers. In this study, we investigated rates tobacco education at ambulatory visits among with active malignancy. Methods: We identified current diagnosis malignancy using the National Ambulatory Medical Care Survey (NAMCS), nationally representative sample US, from 2008 2018. first determined weighted documented counseling. next evaluated sociodemographic characteristics, provider visit type, chronic conditions as determinants population logistic regression. Results: 2,437 total during study period, representing an estimated 48.9 million such US. cohort, was provided 14.2% (95% confidence interval [CI] 12.1-16.7%) visits. Patients were significantly less likely receive older age (adjusted OR 0.97 per year age; 95% CI 0.96-0.98) surgical (OR 0.49; 0.32-0.75) or medical subspecialties 0.60; 0.36-0.99) compared primary care Sex, race, visit, insurance previous same not related receipt concomitant COPD substantially more 3.50; 2.21-5.53), 28.4% 21.5-36.4%) including education. Conclusions: modifiable factor associated malignancies substantial non-neoplastic Nonetheless, only about seven outpatient visits, lower frequency advanced subspecialty As treatments improve survival for cancer patients, further work needed efforts that could quality life.[Table: see text]